Regeneron Pharmaceuticals Inc. buy StockNews.com
Start price
06.01.24
/
50%
€827.00
Target price
06.01.25
-
Performance (%)
-17.32%
End price
07.01.25
€683.80
Summary
This prediction ended on 07.01.25 with a price of €683.80. The price of Regeneron Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.32%. StockNews_com has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. StockNews_com has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 9.990% | 9.990% | -7.630% |
| iShares Core DAX® | -2.673% | -4.643% | 20.572% |
| iShares Nasdaq 100 | -2.173% | -2.819% | 6.609% |
| iShares Nikkei 225® | -3.367% | -3.195% | 15.407% |
| iShares S&P 500 | -1.015% | -1.118% | 2.041% |
Comments by StockNews_com for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€600.60
17.11.25
17.11.25
-
17.11.26
17.11.26
9.40%
21.11.25
21.11.25
Stopped prediction by StockNews_com for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,063.5
24.08.24
24.08.24
-
24.08.25
24.08.25
-52.87%
25.08.25
25.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,072.5
17.08.24
17.08.24
-
17.08.25
17.08.25
-53.23%
18.08.25
18.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€835.40
30.04.24
30.04.24
-
30.04.25
30.04.25
-36.56%
01.05.25
01.05.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€843.20
20.04.24
20.04.24
-
20.04.25
20.04.25
-41.90%
21.04.25
21.04.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€856.40
13.04.24
13.04.24
-
13.04.25
13.04.25
-42.21%
14.04.25
14.04.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€797.00
28.12.23
28.12.23
-
28.12.24
28.12.24
-14.96%
29.12.24
29.12.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€773.00
20.12.23
20.12.23
-
20.12.24
20.12.24
-13.14%
21.12.24
21.12.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€750.00
20.08.23
20.08.23
-
20.08.24
20.08.24
42.67%
21.08.24
21.08.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€735.00
12.08.23
12.08.23
-
12.08.24
12.08.24
40.00%
13.08.24
13.08.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€692.50
05.08.23
05.08.23
-
05.08.24
05.08.24
41.55%
06.08.24
06.08.24